Treatment with two medications that target the most common genetic cause of cystic fibrosis improves lung function and lowers the rate of pulmonary exacerbations, according to results from a Northwestern Medicine clinical trial.
A study from Northwestern Medicine and the American College of Surgeons suggests that penalizing hospitals for patient readmissions following surgery may be ineffective, and even counterproductive for improving the quality of hospital care in the United States.